Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

Celgene spends $7.2bn on Receptos purchase

Celgene spends $7.2bn on Receptos purchase The majority of Celgene's sales come from multiple myeloma treatment Revlimid (lenalidomide), which saw sales growth of 16% last year, bringing revenue for the medicine to $4.9bn.

Roche maintains dominance as leading cancer drugmaker

Roche maintains dominance as leading cancer drugmaker Celgene saw its cancer drug revenue reach $7.4bn, based predominately on sales of its rare blood cancer treatment Revlimid (lenalidomide), which saw growth of 16% last year, bringing revenue for

Celgene sets up stem cell deal with Mesoblast

Celgene sets up stem cell deal with Mesoblast Celgene, which markets the multiple myeloma drug Revlimid, will gain a six-month right of first refusal on Mesoblast's stem-cell product candidates for conditions including inflammatory bowel disease and

Amgen gets quick US review for Kyprolis

Amgen gets quick US review for Kyprolis The filing is underpinned by data from the phase III ASPIRE trial, which showed that patients given Kyprolis, Celgene's Revlimid (lenalidomide) and dexamethasone had greater progression-free survival than those ... Revlimid is the leading first-line

Final NICE ‘no’ for Celgene’s Imnovid

Final NICE ‘no’ for Celgene’s Imnovid Meanwhile, for people who have received two prior treatments, NICE also recommends Revlimid (lenalidomide), another multiple myeloma (MM) medicine from Celgene. ... Imnovid is the next generation version of both Thalidimod and Revlimid and this appraisal

[ Previous 5 results ] 11 12 13 14 15 16 17 18 19 20 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics